By adding an enzyme to adult stem cells 'in vitro', remarkable results can be booked 'in vivo', say scientists of the University of Twente in The Netherlands. Up to now, so-called mesenchymal stem cells could not succesfully be used to create new bone tissue, e.g. for repair. By adding PKA enzyme to the stem cells beforehand, a substantial amount of bone is grown after implanting the cells.
Hitherto it has been difficult to induce adult human stem cells to produce bone, e.g. in order to repair bone tissue. Researchers at the University of Twente have shown that if the enzyme PKA is previously activated in the stem cells in the lab, following implantation this results in substantial bone formation. This opens up new ways of repairing bone tissue using cell material from the patient.
In animals, ‘adult’ mesenchymal stem cells have already been used successfully to grow fresh bone. Bone formation using human adult stem cells, e.g. from bone marrow, has been less successful, which has hitherto limited the alternatives hospitals can offer for repairing damaged tissue other than spontaneous healing. Activating the PKA enzyme prior to implantation, however, produces a dramatic improvement in ‘in vivo’ bone growth. The cells can be observed maturing into bone cells already in the lab; once sown on a carrier and implanted in a mouse, the bone grows well.
